docetaxel anhydrous has been researched along with glucose, (beta-d)-isomer in 6 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saijo, N | 1 |
| Awasthi, S; Fast, S; Nagaprashantha, LD; Roby, R; Singhal, J; Singhal, SS; Vatsyayan, R | 1 |
| Guan, M; Hai, L; Li, X; Qu, B; Wu, Y | 1 |
| Awasthi, S; Horne, D; Jain, D; Singhal, J; Singhal, P; Singhal, SS | 1 |
| Chang, CS; Chang, YY; Hsiao, LC; Lin, HJ; Lin, YF; Liu, DZ | 1 |
| Ahn, KS; Baek, SH; Hwang, ST; Um, JY; Yang, MH | 1 |
2 review(s) available for docetaxel anhydrous and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apigenin; Docetaxel; Drug Resistance, Neoplasm; Glucosides; Humans; Male; Prostatic Neoplasms; Signal Transduction; Taxoids | 2017 |
4 other study(ies) available for docetaxel anhydrous and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Aorta; Apigenin; Apoptosis; Cell Line; Cell Movement; Docetaxel; Drug Synergism; Drug Therapy, Combination; Glucosides; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Taxoids; Time Factors; Tissue Culture Techniques | 2011 |
Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes.
Topics: Administration, Intravenous; Animals; Brain; Docetaxel; Drug Design; Glucosides; Ligands; Liposomes; Mice; Mice, Inbred Strains; Molecular Conformation; Taxoids | 2014 |
Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; MCF-7 Cells; Stilbenes; Zebrafish | 2021 |
Corilagin exhibits differential anticancer effects through the modulation of STAT3/5 and MAPKs in human gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Glucosides; Humans; Hydrolyzable Tannins; Mitogen-Activated Protein Kinases; STAT3 Transcription Factor; Stomach Neoplasms | 2022 |